Mark Zuckerberg-Backed AI Startup Takes Over Parkinson’s Treatment From the Maker of Ozempic
RSS SUMMARY · AGGREGATED FROM GIZMODO
Cellular Intelligence just acquired the rights to an experimental Parkinson’s cell therapy from Novo Nordisk.
Cellular Intelligence just acquired the rights to an experimental Parkinson’s cell therapy from Novo Nordisk.
Cellular Intelligence just acquired the rights to an experimental Parkinson’s cell therapy from Novo Nordisk.
Continue Reading
The full story continues on Gizmodo.
Story Sentry shows a short summary aggregated via RSS. The complete article — original photography, charts, and reporting — lives with the publisher.
The Source
GIZMODO
Tech
‘Westworld’ Is Returning to the Big Screen
GIZMODO·18m ago·3 min read
Tech
Jon Favreau Isn’t Sure Why He Was Asked to Make ‘The Mandalorian and Grogu,’ But He’s Sure Baby Yoda Had Something to Do With It
GIZMODO·58m ago·3 min read
Tech
Elon Musk and Tim Cook Will Travel to China With Trump: Report
GIZMODO·1h ago·3 min read
Tech
Ryan Coogler’s ‘X-Files’ Reboot Adds a Stellar Supporting Cast
GIZMODO·1h ago·3 min read
Related
On this beat
Tech
Palantir’s true believers are wearing this jacket
THE VERGE·47m ago·3 min read
Tech
Robotaxi drives off from airport with passenger’s suitcase
FOX NEWS·1h ago·3 min read
Tech
What is the release date for Half Man episode 4 on HBO Max and BBC iPlayer?
TECHRADAR·1h ago·3 min read
Tech
iOS end-to-end encrypted RCS messaging begins rolling today in beta
ENGADGET·53m ago·3 min read